7C83 image
Deposition Date 2020-05-28
Release Date 2021-01-27
Last Version Date 2024-04-03
Entry Detail
PDB ID:
7C83
Keywords:
Title:
Crystal structure of an integral membrane steroid 5-alpha-reductase PbSRD5A
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.00 Å
R-Value Free:
0.23
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
C 2 2 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:3-oxo-5-alpha-steroid 4-dehydrogenase
Gene (Uniprot):DCC71_03205
Chain IDs:A
Chain Length:258
Number of Molecules:1
Biological Source:Proteobacteria bacterium
Primary Citation
Crystal structure of steroid reductase SRD5A reveals conserved steroid reduction mechanism.
Nat Commun 12 449 449 (2021)
PMID: 33469028 DOI: 10.1038/s41467-020-20675-2

Abstact

Steroid hormones are essential in stress response, immune system regulation, and reproduction in mammals. Steroids with 3-oxo-Δ4 structure, such as testosterone or progesterone, are catalyzed by steroid 5α-reductases (SRD5As) to generate their corresponding 3-oxo-5α steroids, which are essential for multiple physiological and pathological processes. SRD5A2 is already a target of clinically relevant drugs. However, the detailed mechanism of SRD5A-mediated reduction remains elusive. Here we report the crystal structure of PbSRD5A from Proteobacteria bacterium, a homolog of both SRD5A1 and SRD5A2, in complex with the cofactor NADPH at 2.0 Å resolution. PbSRD5A exists as a monomer comprised of seven transmembrane segments (TMs). The TM1-4 enclose a hydrophobic substrate binding cavity, whereas TM5-7 coordinate cofactor NADPH through extensive hydrogen bonds network. Homology-based structural models of HsSRD5A1 and -2, together with biochemical characterization, define the substrate binding pocket of SRD5As, explain the properties of disease-related mutants and provide an important framework for further understanding of the mechanism of NADPH mediated steroids 3-oxo-Δ4 reduction. Based on these analyses, the design of therapeutic molecules targeting SRD5As with improved specificity and therapeutic efficacy would be possible.

Legend

Protein

Chemical

Disease

Primary Citation of related structures